ARCHIVES

HCFA Chief Says Facts Will Not Matter, She Won’t Loosen DRGs For Clinical Trials Unless Congress Orders It

This article is from The Cancer Letter archive.

Vol. 10 No. 18 | May 4, 1984

Download PDF Visit The Full Archive

Related Articles

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998